Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Current Opinion in Rheumatology|March 20, 2008
The role of drug and disease registries in rheumatic disease epidemiologyJoel M Kremer, Allan Gibofsky, Jeffrey D GreenbergClinical Rheumatology|June 5, 2014
Acute rheumatic fever and streptococci: the quintessential pathogenic trigger of autoimmunitySoumya D Chakravarty, John B Zabriskie, Allan GibofskyCurrent Rheumatology Reports|May 7, 2008
The post-NSAID era: what to use now for the pharmacologic treatment of pain and inflammation in osteoarthritisCarla R Scanzello, Neal K Moskowitz, Allan GibofskyArthritis and Rheumatism|November 13, 2003
Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trialAllan Gibofsky, Gary W Williams, Frank McKenna, et al.Clinical Therapeutics|August 19, 2007
Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled studyAllan Gibofsky, Jude Rodrigues, Justus Fiechtner, et al.Expert Opinion on Drug Safety|May 26, 2015
Low-dose SoluMatrix diclofenac : a review of safety across two Phase III studies in patients with acute and osteoarthritis painAllan Gibofsky, Roy Altman, Stephen Daniels, et al.Current Medical Research and Opinion|October 28, 2015
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 studyRoy Altman, Marc Hochberg, Allan Gibofsky, et al.Current Medical Research and Opinion|July 23, 2014
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 studyAllan Gibofsky, Marc C Hochberg, Mark J Jaros, et al.Clinical and Experimental Rheumatology|July 13, 2018
Short-term costs associated with non-medical switching in autoimmune conditionsAllan Gibofsky, Martha Skup, Min Yang, et al.Clinical Rheumatology|February 15, 2017
Low-dose SoluMatrix diclofenac in patients with osteoarthritis pain: impact on quality of life in a controlled trialVibeke Strand, Martin Bergman, Jasvinder A Singh, et al.Pageof 6